Seasonal Allergy

Food Allergy

Anaphylaxis

Allergy

Biosimilars

Dyslipidemia

Arrhythmia

Structural Heart Disease

Atherosclerotic Cardiovascular Disease

Heart Failure

Lipid Management

Hypertension

Stroke

Venous Thromboembolism

Cardiology

Vitiligo

Acne

Atopic Dermatitis

Chronic Idiopathic Urticaria

Plaque Psoriasis

Rosacea

Dermatology

Type 2 Diabetes

Type 1 Diabetes

Polycystic Ovary Syndrome

Hormonal Disorders

Thyroid Disorders

Endocrinology

FDA News

COVID-19

Influenza

Vaccination

Family Medicine

C Difficile Infection

Gastroesophageal Reflux Disease (GERD)

Hepatitis C

Irritable Bowel Syndrome

Peptic Ulcer

Ulcerative Colitis

Gastroenterology

Alzheimer Disease

Parkinson Disease

Geriatrics

Hepatology

Hospital Medicine

HIV/AIDS

Infectious Disease

Internal Medicine

Berger Disease

Chronic Kidney Disease

Nephrology

Epilepsy

Migraine

Tardive Dyskinesia

Traumatic Brain Injury

Neurology

Obesity Management

Geographic Atrophy

Age-Related Macular Degeneration

Diabetic Macular Edema

Uveitis

Ophthalmology

Acute Pain

Chronic Pain

Multiple Sclerosis

Neuropathic Pain

Pain

Pediatrics

PTSD

Addiction

ADHD

Bipolar Disorder

Major Depressive Disorder

Schizophrenia

Psychiatry

Lung Cancer

Pulmonary Fibrosis

Asthma

COPD

Pulmonology

Vasculitis

Sickle Cell

Amyloidosis

Huntington Disease

Lysosomal Storage Disorders

Rare Disease Report®

Lupus

Osteoporosis

Non-radiographic Axial Spondyloarthritis

Ankylosing Spondylitis

Fibromyalgia

Gout

Osteoarthritis

Psoriatic Arthritis

Rheumatoid Arthritis

Spondyloarthritis

Rheumatology

Obstructive Sleep Apnea

Insomnia

Sleep

Plastic surgery

Surgery

Women's Health

News

Media

Medical World News

Podcasts

Shows

State Of Sciences - Presentations

Videos

Webinars

Multimedia Series

CURE Connections®

Insights

Medcast Podcasts

Medcast Videos

News Network

Peer Exchange

Peers & Perspectives

Conferences

Conference Coverage

Conference Listing

Partners

CME/CE

Resources

Interactive Tools

Live Events

Press Release

Publications

Advisory Board

Subscribe

Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.

Articles

The rheumatology month in review highlights top data from the 2023 CCR West, CBT for reducing pain catastrophizing in patients with fibromyalgia, and the link between gout and a reduced likelihood of Alzheimer Disease.

Rheumatology Month in Review: September 2023

Tim Smith joined the MJH Life Sciences team as an assistant editor for HCPLive in August 2022. He graduated from UC Berkeley with a degree in political science, working in multimedia journalism as a staff writer prior to joining MJH. In his spare time, he enjoys reading, watching TV, listening to podcasts, and rock climbing. You can contact him at 

This new synthetic data set could work as a potential resource for training on AI as well as to help facilitate a consensus among clinicians.


Algorithm from Nonstandardized Internet Images of Melanocytic Lesions Shown to Be Effective 

Patrick Campbell is the managing editor of HCPLive. Formerly the editorial lead of Endocrinology Network, Practical Cardiology, and Rheumatology Network, Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. He now helps to lead coverage in each of these respective areas for HCPLive. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

This installment in our Unprevented series examines the growing impact of chronic kidney disease on public health and what those in the field are doing to mitigate this growing crisis. 

A Silent Epidemic: Recognizing Chronic Kidney Disease as a Public Health Crisis

Connor Iapoce is an associate editor for 

 and joined the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to concerts, and playing with his cat Squish. You can reach him at 

A new initiative from the HFSA highlights key findings on heart failure prevalence, risk, mortality and hospitalization rates in the United States. 



HFSA: Nearly 1 in 4 US Adults Will Develop Heart Failure in their Lifetime

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

About Us

Advertise

Editorial

Contact Us

Do Not Sell My Information

Privacy

Terms & Conditions

HCPLive - Clinical news for connected physicians

Facebook

Twitter

LinkedIn

Spotlight

Biosimilars Spotlight

Qazi Corner

Clinical

Arterial Disease

Diabetes

Geriatric Medicine

Hematology

Video Series

Post Conference Perspectives

View

Christopher G. Bunick, MD, PhD, discusses what can be done to improve the standard of care for atopic dermatitis (AD).

Standard of Care in AD

Christopher G. Bunick, MD, PhD, provides an overview of clinical trial outcomes in atopic dermatitis (AD).

Clinical Outcomes in AD Clinical Trials

A dermatology expert discusses how the standard of care EASI scores have been improving with newer atopic dermatitis (AD) therapies.

EASI Scores in AD Treatment

A dermatology expert discusses how numerical rating scale (NRS) is used in atopic dermatitis (AD) clinical trials.

NRS in AD Treatment

Christopher G. Bunick, MD, PhD, discusses underutilized efficacy outcomes in atopic dermatitis (AD) clinical trials. 

AD: Efficacy Outcomes

A dermatology expert provides an overview of the results of the meta-analysis data from the RAD 2023 atopic dermatitis (AD) trial.

RAD 2023 AD Trial: Meta-Analysis Data

Christopher G. Bunick, MD, PhD, shares their clinical approach for switching therapies for atopic dermatitis (AD) treatment. 

AD Clinical Approach: Switching Therapies

Andrew Blauvelt, MD, provides an overview of different treatment options that are available for patients with moderate to severe atopic dermatitis (AD).

Topical and Systemic Treatments for AD

Andrew Blauvelt, MD, provides an overview of the significance of JAK/Stat pathway inhibition in targeting the pathophysiology of atopic dermatology (AD).

Pathophysiology of AD Treatments

An expert discusses treatment selection for atopic dermatitis (AD) based on short and long-term data.

Treatment Selection in AD 

A dermatology expert discusses taking a nuanced approach to interpreting the boxed warnings for JAK inhibitor for atopic dermatitis (AD) treatment.

JAK Inhibitor Safety 

Andrew Blauvelt, MD, discusses upadacitinib for the treatment of atopic dermatitis (AD).

AD Treatment: Upadacitinib 

Andrew Blauvelt, MD, discusses switching therapies for atopic dermatitis (AD) treatment. 

Switching Therapies in AD

Long-term Use and Safety of JAK Inhibitors and Evaluating Efficacy Outcomes in Atopic Dermatitis

 Insights page is a resource for professional video interviews with leading clinical experts and investigators across all specialties of medicine.

Treatment Selection in AD

EP: 1.Standard of Care in AD

EP: 2.Clinical Outcomes in AD Clinical Trials

EP: 3.EASI Scores in AD Treatment

EP: 4.NRS in AD Treatment

EP: 5.AD: Efficacy Outcomes

EP: 6.RAD 2023 AD Trial: Meta-Analysis Data

EP: 7.AD Clinical Approach: Switching Therapies

EP: 8.Topical and Systemic Treatments for AD

EP: 9.Pathophysiology of AD Treatments

EP: 10.Treatment Selection in AD

EP: 11.JAK Inhibitor Safety

EP: 12.AD Treatment: Upadacitinib

EP: 13.Switching Therapies in AD